286 related articles for article (PubMed ID: 24407288)
21. The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors.
Haines E; Schlienger S; Claing A
Cancer Biol Ther; 2015; 16(10):1535-47. PubMed ID: 26176330
[TBL] [Abstract][Full Text] [Related]
22. Studies of the roles of ADP-ribosylation factors and phospholipase D in phorbol ester-induced membrane ruffling.
Hiroyama M; Exton JH
J Cell Physiol; 2005 Feb; 202(2):608-22. PubMed ID: 15389577
[TBL] [Abstract][Full Text] [Related]
23. EFA6 controls Arf1 and Arf6 activation through a negative feedback loop.
Padovani D; Folly-Klan M; Labarde A; Boulakirba S; Campanacci V; Franco M; Zeghouf M; Cherfils J
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12378-83. PubMed ID: 25114232
[TBL] [Abstract][Full Text] [Related]
24. Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation.
Waters SB; Chen D; Kao AW; Okada S; Holt KH; Pessin JE
J Biol Chem; 1996 Jul; 271(30):18224-30. PubMed ID: 8663461
[TBL] [Abstract][Full Text] [Related]
25. Arf1 and Arf6 promote ventral actin structures formed by acute activation of protein kinase C and Src.
Caviston JP; Cohen LA; Donaldson JG
Cytoskeleton (Hoboken); 2014 Jun; 71(6):380-94. PubMed ID: 24916416
[TBL] [Abstract][Full Text] [Related]
26. Role of SNTA1 in Rac1 activation, modulation of ROS generation, and migratory potential of human breast cancer cells.
Bhat HF; Baba RA; Adams ME; Khanday FA
Br J Cancer; 2014 Feb; 110(3):706-14. PubMed ID: 24434436
[TBL] [Abstract][Full Text] [Related]
27. Interaction of the N terminus of ADP-ribosylation factor with the PH domain of the GTPase-activating protein ASAP1 requires phosphatidylinositol 4,5-bisphosphate.
Roy NS; Jian X; Soubias O; Zhai P; Hall JR; Dagher JN; Coussens NP; Jenkins LM; Luo R; Akpan IO; Hall MD; Byrd RA; Yohe ME; Randazzo PA
J Biol Chem; 2019 Nov; 294(46):17354-17370. PubMed ID: 31591270
[TBL] [Abstract][Full Text] [Related]
28. Active Arf6 recruits ARNO/cytohesin GEFs to the PM by binding their PH domains.
Cohen LA; Honda A; Varnai P; Brown FD; Balla T; Donaldson JG
Mol Biol Cell; 2007 Jun; 18(6):2244-53. PubMed ID: 17409355
[TBL] [Abstract][Full Text] [Related]
29. ARF1 and ARF6 are dispensable for Crk-dependent epithelial-mesenchymal-like transitions.
Lamorte L; Park M
Anticancer Res; 2003; 23(3A):2085-92. PubMed ID: 12894582
[TBL] [Abstract][Full Text] [Related]
30. Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.
Northey JJ; Dong Z; Ngan E; Kaplan A; Hardy WR; Pawson T; Siegel PM
J Biol Chem; 2013 Feb; 288(7):5210-22. PubMed ID: 23277357
[TBL] [Abstract][Full Text] [Related]
31. p66shc inhibits insulin-like growth factor-I signaling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation.
Xi G; Shen X; Clemmons DR
J Biol Chem; 2010 Mar; 285(10):6937-51. PubMed ID: 20048152
[TBL] [Abstract][Full Text] [Related]
32. The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside.
Sabe H; Hashimoto S; Morishige M; Hashimoto A; Ogawa E
Cell Adh Migr; 2008; 2(2):71-3. PubMed ID: 19262097
[TBL] [Abstract][Full Text] [Related]
33. GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway.
Hu Z; Xu R; Liu J; Zhang Y; Du J; Li W; Zhang W; Li Y; Zhu Y; Gu L
Exp Cell Res; 2013 Aug; 319(13):1932-1941. PubMed ID: 23747719
[TBL] [Abstract][Full Text] [Related]
34. p66Shc isoform down-regulated and not required for HER-2/neu signaling pathway in human breast cancer cell lines with HER-2/neu overexpression.
Xie Y; Hung MC
Biochem Biophys Res Commun; 1996 Apr; 221(1):140-5. PubMed ID: 8660324
[TBL] [Abstract][Full Text] [Related]
35. Non-canonical dynamic mechanisms of interaction between the p66Shc protein and Met receptor.
Landry M; Pomerleau V; Saucier C
Biochem J; 2016 Jun; 473(11):1617-27. PubMed ID: 27048591
[TBL] [Abstract][Full Text] [Related]
36. ADP-ribosylation factor 6 expression and activation are reduced in myometrium in complicated pregnancies.
Kanamarlapudi V; Owens SE; Lartey J; López Bernal A
PLoS One; 2012; 7(5):e37954. PubMed ID: 22666423
[TBL] [Abstract][Full Text] [Related]
37. Differential expression and targeting of endogenous Arf1 and Arf6 small GTPases in kidney epithelial cells in situ.
El-Annan J; Brown D; Breton S; Bourgoin S; Ausiello DA; Marshansky V
Am J Physiol Cell Physiol; 2004 Apr; 286(4):C768-78. PubMed ID: 14684384
[TBL] [Abstract][Full Text] [Related]
38. Arf6 coordinates actin assembly through the WAVE complex, a mechanism usurped by Salmonella to invade host cells.
Humphreys D; Davidson AC; Hume PJ; Makin LE; Koronakis V
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16880-5. PubMed ID: 24085844
[TBL] [Abstract][Full Text] [Related]
39. Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras.
Pronk GJ; de Vries-Smits AM; Buday L; Downward J; Maassen JA; Medema RH; Bos JL
Mol Cell Biol; 1994 Mar; 14(3):1575-81. PubMed ID: 8114695
[TBL] [Abstract][Full Text] [Related]
40. HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling.
Hartman Z; Zhao H; Agazie YM
Oncogene; 2013 Aug; 32(35):4169-80. PubMed ID: 23027125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
